Clinical Trial Update: A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating Anginera in patients undergoing CABG surgery for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Anginera

Snippet

Sponsor: Theregen, Inc. | Conditions: Coronary Artery Disease | Phase 1 | Status: UNKNOWN